Quant ratings on Cathie Wood's top holdings: TSLA, CRSP, AMD, and TEM

Quant ratings on Cathie Wood's top holdings: TSLA, CRSP, AMD, and TEM
Cathie Wood’s Ark Invest leaned into volatility on Wednesday, buying shares of Tempus AI after a post-earnings pullback while trimming exposure to Pinterest following recent weakness in its outlook. Tempus AI shares fell more than 7% to $53.71 after the company reported a https://t.co/0IaJbvpWYn
Nancy Pelosi’s investment in Tempus AI is turning heads after the stock surged more than 200% this year. Earlier in 2025, Pelosi disclosed the purchase of 50 call options in Tempus AI, a healthcare-focused artificial intelligence company. The options, which expire in 2026 with a https://t.co/RQcfR1BVPT
Cathie Wood’s Ark Invest made a series of high-profile moves on Tuesday, reshuffling its portfolio across several sectors. The firm increased exposure to Advanced Micro Devices, Bullish, and Figma, while trimming its stake in Tempus AI. Ark’s Fintech Innovation ETF added nearly https://t.co/QvBQeiAvDv
Cathie Wood’s Ark Invest made several high-profile trades this week, shifting away from Tempus AI while increasing positions in Amazon, Figma, and crypto-focused Bullish. Ark sold more than 58,000 shares of Tempus AI across its ARK Genomic Revolution and ARK Innovation funds. https://t.co/DTZ8k1O1wA
Tempus AI announces $81.25M acquisition of Paige
7.48BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US88023B1035
CUSIP
-
Sector
Healthcare
Industry
Health Information Services
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
2.32
Dividend Share
-
Dividend Yield
-
Earnings Share
-1.83
Wall Street Target Price
67.23
EPS Estimate Current Year
-0.36
EPS Estimate Next Year
-0.08
EPS Estimate Current Quarter
-0.2011
EPS Estimate Next Quarter
-0.1483
Most Recent Quarter
-
Revenue TTM
1,364,167,936
Gross Profit TTM
864,734,976
EBITDA
-185,246,000
Profit Margin
-22.21%
Return On Assets TTM
-9.07%
Return On Equity TTM
-81.58%
Revenue Per Share TTM
7.735
Qtly Revenue Growth YOY
36.10%
Diluted Eps TTM
-1.83
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
5.846
Price Book MRQ
17.9669
Enterprise Value Revenue
5
Enterprise Value EBITDA
0
0.97
5.32%203.19
0.55%21.11
0.26%112.23
0.00%59.68
-18.13%46.54
-5.87%5.92
-2.20%74.71
-0.65%49.87
-0.53%100.62
-0.39%